A Study of Massage Therapy Alone and in Combination with Acupuncture for Breast Cancer Patients Undergoing Autologous Tissue Reconstruction
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 15-004621
Sponsor Protocol Number: 15-004621
About this study
The purpose of this study is to explore the effectiveness of massage therapy combined with acupuncture in breast cancer patients recovering from autologous tissue reconstruction with the hope that the combination will augment the benefit obtained by massage therapy alone.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Female
- Has breast cancer
- Will undergo a mastectomy and the following autologous tissue reconstruction
- Free TRAM flaps (Transverse Rectus Abdominis Myocutaneous)
- Muscle-sparing free TRAM flaps (or MS-TRAM)
- DIEP flaps (Deep Inferior Epigastric Perforator)
- SIEA flaps (Superficial Inferior Epigastric Artery)
- Pedicled TRAM flaps
- Will undergo surgery on Monday or Tuesday (massage or massage combined with acupuncture on postoperative days 1-3, plus or minus 1 day for beginning treatment)
- Able to speak English
- Able to complete the questionnaires
- Sign informed consent
Exclusion Criteria
- Taking anticoagulation medication (e.g. coumarin, heparin, warfarin)
- Severe immunocompromised state
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Christina Dilaveri, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available